Subcutaneous Compared with Intravenous Epoetin in Patients Receiving Hemodialysis

Abstract
Several studies have suggested that if recombinant human erythropoietin (epoetin) is administered subcutaneously rather than intravenously, a lower dose may be sufficient to maintain the hematocrit at a given level.

This publication has 23 references indexed in Scilit: